Anti-Vegf Therapy for Ocular Diseases: Present and Future-Reference-Cited by-同舟云学术

Anti-Vegf Therapy for Ocular Diseases: Present and Future

Published:2020-09-18 Issue:12 Volume:21 Page:1158-1158
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Campa Claudio¹,Parodi Maurizio Battaglia²

Affiliation:

1. Department of Ophthalmology Sant’Anna University Hospital Ferrara, Italy

2. Department of Ophthalmology University Vita-Salute San Raffaele Milan, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Reference7 articles.

1. Miller J.W.; Adamis A.P.; Shima D.T.; D’Amore P.A.; Moulton R.S.; O’Reilly M.S.; Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994,145,574-584

2. Kim L.A.; D'Amore P.A.; A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol 2012,181,376-379

3. Parodi M.B.; Iacono P.; Da Pozzo S.; Anti-VEGF and Retinal Dystrophies. Curr Drug Targets Online ahead of print2020

4. Vilela MA.; Use Of Anti-Vegf Drugs In Retinal Vein Occlusions Curr Drug Targets Online ahead of print2020

5. Giannaccare G.; Pellegrini M.; Bovone C.; Spena R.; Senni C.; Scorcia V.; Busin M.; Anti-VEGF Treatment in Corneal Diseases Curr Drug Targets Online ahead of print2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Framework Nucleic Acids Loaded with Quercetin: Protecting Retinal Neurovascular Unit via the Protein Kinase B/Heme Oxygenase-1 Pathway;ACS Nano;2024-09-13

2. Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases;Advanced Science;2024-06-21

3. VEGF signaling: Role in angiogenesis and beyond;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03